[Form 4] DENTSPLY SIRONA Inc. Insider Trading Activity

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. director reports open-market stock purchase

A director of DENTSPLY SIRONA Inc. (XRAY) reported buying common stock in the company. On 11/24/2025, the reporting person purchased 9,337 shares of common stock at a price of $10.71 per share, in an open-market transaction coded as a purchase. After this transaction, the director beneficially owns 57,342.925 shares of DENTSPLY SIRONA common stock, held directly. This filing is a routine Form 4 disclosure of insider trading activity required under U.S. securities regulations.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

VARON LESLIE F

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NC 28277

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/24/2025		P		9,337	A	$10.71	57,342.925	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Jessica Nielsen Causey, Attorney-in-Fact for Leslie F. Varon	11/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did DENTSPLY SIRONA (XRAY) report on this Form 4?

The filing reports that a director of DENTSPLY SIRONA Inc. (XRAY) purchased 9,337 shares of common stock in an open-market transaction.

On what date did the DENTSPLY SIRONA (XRAY) director buy shares?

The earliest transaction date disclosed is 11/24/2025.

What price did the DENTSPLY SIRONA (XRAY) director pay per share?

The director purchased the common stock at a price of $10.71 per share.

How many DENTSPLY SIRONA (XRAY) shares does the director own after the transaction?

Following the reported transaction, the director beneficially owns 57,342.925 shares of DENTSPLY SIRONA common stock, held directly.

What is the relationship of the reporting person to DENTSPLY SIRONA (XRAY)?

The reporting person is identified as a Director of DENTSPLY SIRONA Inc.

Were any derivative securities reported in this DENTSPLY SIRONA (XRAY) Form 4?

The section for derivative securities is present but does not list any specific derivative transactions in the provided content.

Is this DENTSPLY SIRONA (XRAY) Form 4 filed for one or multiple reporting persons?

The document indicates it is a Form filed by One Reporting Person.